Skip to main content
. 2020 Jan 21;19:34. doi: 10.1186/s12936-020-3121-3

Table 3.

Day 4 and day 8 gametocyte prevalence adjusted for baseline gametocyte density

Variable Gametocyte prevalence n/N OR (95% CI) p value
Day 4 prevalence
 AL only 8/30 Ref.
 AL + primaquine day 1 4/35 0.28 (0.06 – 1.37) 0.116
 AL + primaquine day 3 8/31 0.79 (0.21 – 3.00) 0.726
Day 8 prevalence
 AL only 4/30 Ref.
 AL + primaquine day 1 0/35
 AL + primaquine day 3 2/31 0.51 (0.07 – 3.60) 0.502

AL artemether–lumefantrine, OR odds ratio, CI confidence interval